Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04129242 · ClinicalTrials.gov registry record · Early Phase 1
taVNS for Upper Limb Rehabilitation
A Early Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
NCT04129242 is a Early Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 20 participants.
The verdict
NCT04129242, a Early Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study explores the use of a new form of neuromodulation known as transcutaneous auricular vagus nerve stimulation (taVNS) which stimulates the ear. This stimulation will be delivered concurrently with upper limb motor rehabilitation training (3 days/week for 4 weeks) in chronic stroke patients. Patients will undergo a series of baseline assessments (including a brain scan), a 4-week course of motor rehabilitation, and post-assessments (including a second brain scan)
Interventions
- DEVICE Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-02-19 |
| Est. Completion | 2022-10-05 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04129242
The ClinicalTrials.gov registry entry for NCT04129242 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc Training is the first listed.
NCT04129242 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04129242 about?
NCT04129242 is a clinical study titled "taVNS for Upper Limb Rehabilitation". This study explores the use of a new form of neuromodulation known as transcutaneous auricular vagus nerve stimulation (taVNS) which stimulates the ear. This stimulation will be delivered concurrently with upper limb motor rehabilitation training (3 days/week for 4 weeks) in chronic stroke patients....
What is the current status of trial NCT04129242?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2020-02-19. Estimated completion is 2022-10-05.
What interventions are being tested in trial NCT04129242?
The interventions under investigation include: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc Training (DEVICE).
Who is sponsoring clinical trial NCT04129242?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.